- Open Access
Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice
Journal of Cardiovascular Magnetic Resonance volume 25, Article number: 18 (2023)
Late gadolinium enhancement (LGE) imaging has become one of the cornerstones of the core cardiovascular magnetic resonance (CMR) examination . Also known as delayed enhancement imaging, LGE enables the differentiation of viable from non-viable myocardium in a wide range of patients with ischemic and non-ischemic myocardial disease and is now considered the imaging reference standard for the diagnosis of myocardial infarction and scarring.
With the increased adoption of CMR by the cardiovascular community, LGE is being more frequently performed in patients with significant comorbidities, such as acute heart failure and arrhythmias. In these patients, optimization of acquisition parameters can significantly improve image quality. Moreover, new LGE techniques, including dark blood delayed enhancement, have been described and appear to have additive clinical utility. Thus, it is timely to present an update on how we perform LGE at our center . We will review the sequence variants used, key imaging parameters, as well as the adjustments that can be made to optimize image quality, and highlight potential pitfalls that we have encountered in our experience using this method over the last 25 years. We will also end with a brief discussion of image interpretation focused on the assessment of myocardial viability in patients with chronic ischemic heart disease.
LGE imaging is a fundamental component of the core CMR examination. The inclusion of LGE imaging allows the simultaneous visualization of both infarcted and normal myocardium. At our center, LGE imaging is performed in the vast majority (> 98%) of studies. LGE images are typically acquired after cine imaging and other morphologic imaging or mapping. When vasodilator stress perfusion imaging is also performed, LGE is typically obtained after rest perfusion imaging. When vasodilator stress perfusion imaging is also performed, LGE is used to both differentiate infarcted from ischemic myocardium and to distinguish true ischemic perfusion defects from perfusion imaging artifacts.
Contrast dose and type
We typically administer 0.15 mmol/kg of gadolinium contrast media for viability imaging alone or 0.2 mmol/kg in two divided doses during vasodilator stress and rest perfusion imaging. Lower doses of contrast media can be considered for viability imaging, however, this may reduce the diagnostic performance of the LGE imaging, particularly at 1.5 T . The relationship between LGE diagnostic accuracy and contrast dose was demonstrated in an international multicenter study which evaluated the performance of LGE for the detection of myocardial infarction (MI) (Fig. 1). This study found a significant dose–response relationship (both P < 0.0001) of gadoversetamide with sensitivity and accuracy for infarction location increasing with rising contrast dose .
There are several factors that merit consideration when selecting a gadolinium-based contrast agent (GBCA) for LGE imaging. At our center, we use group II GBCAs due to their favorable safety profiles with few (if any) associated cases of nephrogenic systemic fibrosis . We also find that the rate of contrast agent clearance from the blood pool is an important consideration when choosing a contrast agent for LGE. For example, albumin binding GBCAs provide relatively persistent and high blood pool enhancement, often for more than 10–20 min following contrast administration. Although helpful for contrast enhanced CMR angiography, the long duration of blood pool enhancement with albumin binding GBCAs can be problematic for LGE imaging since the blood pool signal and adjacent subendocardial LGE (if present) will have similar (bright) image intensities, potentially leading to difficulty in consistently identifying subendocardial MI. At the other end of the spectrum, we have found that some GBCAs exhibit very rapid clearance from the body. The latter can be problematic (especially for less experienced operators) because there is a relatively short time window during which LGE images with optimal image contrast can be acquired. In instances for which image quality is insufficient, a small additional dose of contrast can be considered.
LGE sequence variants and image timing
Our imaging protocol for LGE utilizes the following pulse sequence variants for most patients:
Bright blood 2D free breathing single shot inversion recovery (SSIR) balanced steady state free precession (bSSFP)
Bright blood segmented 2D breath held inversion recovery (IR) fast gradient echo (GRE) or segmented 2D breath held flow independent dark blood delayed enhancement (FIDDLE).
We typically begin SSIR-bSSFP image acquisition within 2–3 min of contrast administration (Fig. 2). Image stacks are prescribed over the entire heart in the short axis and in the LV 2-chamber orientation. These images are acquired free breathing with a high inversion time (TI; ~ 600 ms at 1.5 T and ~ 875 ms at 3 T), which nulls thrombus or regions of myocardium with microvascular obstruction (MVO). Next, the imaging stacks are repeated in both orientations with a TI set to null normal myocardium. Third, breatheld segmented IR-GRE and/or FIDDLE images are acquired in the left ventricular (LV) short and long axis views (2-, 3-, and 4- chamber views). In patients in whom mural thrombus or MVO is initially suspected, the SSIR-bSSFP images with the long TI can be repeated in order to help differentiate between the two tissue types (see Inversion Time Section for more details).
We do not use a standard or fixed wait time (e.g., ~ 8–10 min after contrast administration) before starting LGE imaging for two reasons. First, intracardiac thrombi and regions of myocardium with MVO are visible immediately after contrast administration on SSIR-bSSFP images with a high TI. Second, when attempting to visualize infarction or scar, there is substantial patient to patient variation in the clearance of contrast, and using a fixed wait time before acquiring LGE images can result in missing the optimal imaging window in individuals with rapid contrast clearance. Given these considerations, we begin high TI LGE imaging shortly after contrast administration.
These different pulse sequence variants for LGE imaging can be complementary within the same patient. With SSIR-bSSFP, image acquisition is fast and does not require breath holding, permitting a rapid survey of the heart. With the segmented sequences, spatial and temporal resolutions are higher than for SSIR-bSSFP, however, breath holding is required to eliminate image ghosts due to respiratory motion. For segmented IR-GRE, the higher resolution leads to improved sensitivity for the detection of scar and better visualization of MI transmurality as compared to the single shot variant .
Over the last ~ 15 years, we have added the FIDDLE imaging protocol. This is because dark blood LGE techniques further improve the identification of myocardium with contrast enhancement . In particular, with standard bright blood LGE techniques (SSIR-bSSFP or IR-GRE), the hyperintense signal intensity of the LV cavity, caused by the presence of intravascular contrast material, reduces the contrast-to-noise ratio between blood and infarcted myocardium and hampers clear infarct delineation. In patients with subendocardial MI or scarring, this is often problematic since the infarct can be indistinguishable from the adjacent blood pool, potentially leading to a missed or erroneous diagnosis (Fig. 3). In patients, FIDDLE has been shown to have improved diagnostic performance for the diagnosis of MI as compared to conventional bright blood IR-GRE (sensitivity: 96% vs 85%, respectively, p = 0.002; accuracy: 95% vs 87%, p = 0 0.01) .
An alternative to segmented breatheld bright blood IR-GRE is the acquisition of multiple SSIR-bSSFP images that are subsequently motion corrected, co-registered, and averaged . The technique produces images that have hybrid characteristics of the SSIR-bSSFP and segmented IR-GRE. Similar to an individual SSIR-bSSFP image acquisition, ghosting artifacts due to respiratory motion are not present, while the spatial and temporal resolutions are comparable to that of segmented IR-GRE through the application of parallel imaging. The signal-to-noise ratio (SNR) loss associated with parallel imaging is offset through averaging of the images (typically 8 averages, acquired over 16 heart beats). In the LV short axis orientation, motion correction is able to account for variations in the in-plane position of the heart, and the sequence provides image quality that is similar to that segmented IR-GRE, but without the requirement for breath holding. However, in the LV long axis views, image co-registration can be inaccurate due to the greater through-plane motion of the heart associated with free breathing, potentially producing artifacts within the composite image. Nonetheless, the technique is very helpful in patients who are unable to comply with breath holding instructions.
Pulse sequence parameters
In this section, we will discuss the parameters of the bright blood and dark blood pulse sequences used at our center and describe how we train operators to make patient specific adjustments.
Bright blood SSIR-bSSFP and segmented IR-GRE
Typical pulse sequence parameters at 1.5 T and 3 T for the SSIR-bSSFP and segmented IR-GRE implementations used at our center are shown in Table 1 and 2. LGE images are obtained in short axis views (~ 7 mm slice thickness, 3 mm gap) every 10 mm from the mitral valve insertion to the LV apex, as well as in 3 dedicated long axis view 4-chamber, 3-chamber, and 2-chamber). The timing diagram for segmented IR-GRE is shown in Fig. 4. As technical details of the pulse sequences have been described elsewhere [2, 8,9,10], we will focus upon the key parameters that our scan operators commonly adjust in order to improve image quality.
Data acquisition window
The time during which the image K-space data are acquired by the CMR scanner is the data acquisition window (Fig. 4). For both SSIR-bSSFP and segmented IR-GRE implementations, the scan operator may adjust the location and/or the duration of the acquisition window with the goal of limiting the impact of cardiac motion on image quality.
The location of the acquisition window is adjusted to occur in mid-diastole of the cardiac cycle when the heart is relatively motionless. Typically, the acquisition window is ~ 200 ms in duration in patients with heart rates between ~ 45 and 100 bpm (Fig. 5). The end of the acquisition window corresponds to the end of the diastolic standstill period and usually occurs prior to the P-wave of the electrocardiogram (ECG) tracing. If there is ambiguity when LGE imaging should be performed (e.g., due to dys-synchronous contraction associated with left bundle branch block), operators can use cine imaging to identify the standstill location and duration more precisely.
The duration of the acquisition window is the temporal resolution for LGE imaging and is determined by the number of K-space lines (segments or view per segment) per heart beat. There are several factors to consider when adjusting the duration of the acquisition window depending upon the sequence used.
For segmented implementations, the acquisition of K-space occurs incrementally over several heart beats. The number of phase encoding lines acquired in each heart beat determines temporal resolution (number of phase encoding lines multiplied by repetition time; e.g., 23 lines × 8.8 ms = 202.4 ms). When fewer lines are acquired per heart beat, the temporal resolution is shorter but the total number of heart beats (and breath hold time) to acquire the data needed for reconstruction is higher (matrix size divided by segments).
For single shot implementations, all the K-space lines for an image are acquired in a single heart beat. The temporal resolution is determined by the total number of K-space lines acquired in phase-encoding direction and the parallel imaging acceleration factor. For any given matrix size and acceleration factor, the number of K-space lines acquired alters the temporal resolution (e.g., more lines, increases readout duration). As such, single shot implementations are typically limited by worse spatial resolution for the same temporal resolution as compared to segmented implementations.
Altering the duration of the acquisition window or temporal resolution may be advantageous in specific instances for segmented K-space implementations (Fig. 5). For example, in patients with significant tachycardia (~ > 100 bpm), reducing the number of segments may improve image sharpness since temporal resolution is improved (shorter; e.g., 17 segments × 8.8 ms = 149.6 ms). Conversely, increasing the number of segments (e.g., 29 segments × 8.8 ms = 255 ms) may provide acceptable temporal resolution with minimal change in image sharpness when the heart rate is slow (~ < 45 bpm) since the diastolic standstill period is longer. The latter change carries the additional benefit of reducing the overall breath hold time.
Adjustments to the location of the acquisition window are typically required in patients with irregular arrhythmias, such as atrial fibrillation (AF). In patients with AF, the length of the cardiac cycle is variable, and when one compares one R–R interval to another, the main difference between heart beats is the duration of diastole (Fig. 6a). In other words, the duration of systole between heart rates in patients with AF is relatively similar, while the duration of diastole may be variable. Accordingly, at our center, we adjust the location of the data acquisition so that imaging occurs at the end of systole/early diastole. For most patients with AF, we adjust the timing such that the end of the image readout occurs prior to the end of the shortest R–R interval between heart beats (Fig. 6b). This strategy can be adapted for other irregular heart rhythms and is compatible with both single shot and segmented acquisitions.
Since successive IR preparation pulses are used to impart T1 weighting, wait beats are used to allow the recovery of longitudinal magnetization between pulses (Fig. 4). The gating factor controls the number of heart beats (or wait beats) between IR pulses. For patients with typical heart rates (~ > 45– < 100 bpm), a gating factor of 2 (one wait beat between IR pulses) is sufficient to allow for the majority of the longitudinal magnetization to recover (Fig. 7). However, in patients with tachycardia, a gating factor of 3 (2 wait beats) is preferable since the time between IR pulses is shorter and image intensity differences between enhanced and normal myocardium are better maintained. Conversely, in patients with significant bradycardia, a gating factor of 1 (0 wait beats) can be sufficient to achieve recovery of longitudinal magnetization.
The TI is defined as the time between the end of the non-selective inversion preparation to the center of k-space data acquisition (for a linear reordering, Fig. 4). Historically, the selection of TI for bright blood LGE has been one of the more difficult parameters for operators to learn to adjust accurately. Fortunately, the development of phase sensitive reconstruction (PSIR) , has greatly simplified the process. Using PSIR, operators are able to obtain high quality LGE images without the need for precise optimization of the TI. Nonetheless, we find that an understanding of how the TI is manually selected has clinical utility, and this knowledge can be used to identify specific pathologies, such as intracardiac thrombi or cardiac amyloidosis.
For manual selection of the TI, the goal is to select the TI so that the longitudinal magnetization of normal myocardium reaches just past the zero crossing (Fig. 8a), thereby ‘nulling’ normal myocardium. This TI also maximizes the difference in magnetization (and consequently, image intensity; Fig. 8b) between infarcted and normal myocardium.
Inaccurate selection of the TI may lead to missed detection of infarcts and incorrect infarct sizing, particularly if the TI selected is too short. In general, selection of TIs that are longer than the normal myocardium zero crossing maintains the difference in image intensities between normal and infarcted myocardium over a reasonable range. However, selection of TIs that are shorter than the normal myocardium zero crossing may create ambiguity in the relative image intensities of normal and infarcted myocardium (Fig. 8, red box). Specifically, when TIs that are somewhat shorter than the null time for normal myocardium are selected, differences in image intensity between normal and infarcted myocardium are variable or may even disappear. As a result, we train operators to select a slightly longer inversion time than the normal myocardium zero crossing in order to avoid acquiring images for which the TI may be too short ((Fig. 8, green box).
At our center, our operators are trained to manually adjust the TI by imaging iteratively with different inversion times. In general, a TI of 300 ms at 1.5 T or 400 ms at 3 T when using a linear K-space trajectory (50–100 ms shorter if centric) is a reasonable first estimate of the TI assuming a contrast dose 0.15 mmol/kg. One could consider reducing the initial TI estimate if a higher dose of contrast is given, imaging performed earlier after contrast administration, or the rate of contrast clearance is anticipated to be reduced.
The process for iteratively selecting the TI is shown in Fig. 9. In particular, we recommend that the operators learn to recognize when the TI is slightly too short. In this instance, myocardium will exhibit an ‘etched’ appearance due partial volume effects (see Fig. 8 legend). In most cases, the optimal TI can be identified after 1 or 2 “test” images. As the time after contrast injection increases, the optimal TI usually becomes longer. Thus, typically, the TI will need to be slowly incremented (e.g., 10–20 ms) to higher values based on the image appearance over the course of the examination.
A Look-Locker sequence or TI scout can also be used to provide an initial estimate of the TI . However, due to readout effects and sampling interval errors, the Lock-Locker sequence only provides a reasonable first approximation of the optimal TI, usually underestimating the optimal TI by as much as 50 ms. Accordingly, additional manual iteration is still usually required to identify the optimal TI following the use of a Look-Locker sequence.
LGE with PSIR is an important method that reduces the complexity of TI selection . The method allows the operator to select a “default” TI value to reconstruct images in which normal myocardium appears nulled by combining data from the conventional LGE acquisition with a second data acquisition (known as the ‘reference’). The “reference” data is acquired during the wait beat and is used for the phase sensitive reconstruction. The reference data are used to resolve the sign of longitudinal magnetization of a tissue species following the inversion preparation (e.g., used to determine if a tissue is at, above, or below zero/null point). Accordingly, following phase sensitive reconstruction, the image intensities on the PSIR image will be rendered based on relative T1. Tissue species with longest T1 (e.g., such as pericardial or pleural fluid) are displayed with the darkest image intensity. Viable myocardium has an intermediate relative T1 and is also dark but less dark than long T1 species. Tissue species with short T1 (e.g., myocardium with LGE or fat) will be displayed with the highest relative image intensity. Importantly, the differences in relative image intensity between normal myocardium and infarcted myocardium are maintained over a fairly wide range of TI times and obviates the problem of setting the TI too short.
As LGE imaging is typically acquired with a gating factor of two, the inclusion of PSIR comes at no cost in terms of breath-hold duration or SNR, and thus, our standard protocol includes PSIR. One caveat, however, is that a moderate degree of co-registration between the magnitude and reference data is required in order to avoid errors in the determination of phase for the PSIR image. Co-registration errors can occasionally occur in the PSIR image if large beat to beat changes in heart position occur due to respiratory motion or ectopy. In our experience, this is rarely an issue for breath held implementations as the amount of mis-registration is negligible. However, when using free breathing single shot implementations, mis-registration can be more common. The result can be inaccurate rendering of image intensity in the cardiac structures. Fortunately, in these instances, the magnitude reconstruction is still interpretable, provided that the TI was selected appropriately. For this reason, we teach operators to manually adjust the TI to null normal myocardium even when using PSIR, ensuring that both the magnitude and PSIR images are interpretable.
As noted earlier, one advantage of having a high level of proficiency in adjusting the TI enables operators to easily adapt bright blood LGE imaging to identify other pathologies, including intracardiac thrombi, MVO associated with acute MI, and cardiac amyloidosis. Typically, a change in approach to setting the TI can be used to highlight these pathologic findings.
Identification of intracardiac thrombi by LGE imaging exploits the principle that thrombi are generally avascular and do not display contrast enhancement . In other words, while tissue species with perfusion take up contrast (leading to reduction in their T1), there is no significant change in the T1 of thrombus post-contrast. Consequently, the inversion time that nulls thrombus prior to contrast administration is the same TI post contrast. In our laboratory, this TI was empirically determined to be ~ 600 ms at 1.5 T and ~ 875 ms at 3 T (Fig. 10, top). Using this ‘high’ TI, thrombi will appear black, while other tissues with perfusion or blood will appear gray or bright (Fig. 10, bottom) on the LGE magnitude reconstruction. We find that this binary (e.g., black vs bright) image appearance is helpful in facilitating rapid identification of intracardiac thrombi. As a result, we perform high TI imaging for thrombi in all patients using the SSIR-bSSFP sequence variant in the short axis and 2-chamber image stacks shortly after contrast administration (see acquisition timeline in Fig. 2). Imaging in the 2-chamber orientation allows the visualization of the left atrial appendage in a longitudinal axis.
While thrombi can also be identified by standard LGE imaging by using PSIR (e.g., without selecting a high TI), the image appearance will not be binary. Instead, since tissue species are rendered according to their relative T1, fluid, thrombus, and viable myocardium will all appear dark. Specifically, fluid will have the most negative relative image intensity value (e.g., most dark), followed by thrombus, and then by viable myocardium (e.g., least dark). Adjusting the image window and level is often necessary to bring out differences in image intensities in these structures.
An added benefit of performing high TI SSIR-bSSFP imaging is that it enables the identification of MVO (“no-reflow”). The same high TI LGE technique used for thrombus imaging can also serve to identify acute infarcts with damaged microvasculature. In infarcts with MVO, there is minimal to no contrast enhancement early after contrast (e.g., the T1 in this region is long) and appear dark (hypointense). However, over the subsequent ~ 10–60 min, there is gradual contrast enhancement (via diffusion) beginning from the outer rim of infarct towards the central core (Fig. 11). The time course of contrast enhancement distinguishes MVO from thrombus, as the latter typically does not demonstrate appreciable contrast enhancement (with the possible exception of some chronic thrombi demonstrating an enhancing fibrotic cap). Thus, in patients with hypointense (dark) regions on early high-TI SSIR-SSFP, we repeat the sequence prior to ending the examination (typically ~ 20 min after contrast administration).
Setting an appropriate TI in patients with cardiac amyloidosis may be challenging . In our experience, we have found that this difficulty can be due to heterogeneity in contrast kinetics among patients with cardiac amyloidosis. In one subset of these patients, the contrast kinetics are markedly altered. The T1 of amyloid infiltrated myocardium is significantly shorter than blood T1, even early after contrast administration. In this circumstance, operators will find that they are unable to ‘null’ the myocardium using a typical TI, perhaps because the majority of the myocardium is abnormal and there is no ‘normal’ myocardium that can be nulled. Instead, we find that choosing an TI to null blood will highlight the extent of cardiac involvement (Fig. 12). In these patients, a TI scout can be used to quickly identify this alteration in contrast kinetics (e.g., the amyloid infiltrated myocardium is nulled at an TI that is shorter than blood) and to aid in selecting the appropriate TI to null blood (Fig. 11). In another subset of patients with cardiac amyloid, the contrast kinetics of amyloid infiltrated myocardium are conceptually similar to scar: the T1 of blood and amyloid infiltrated myocardium are both similarly short. In this case, the TI can be adjusted in the normal fashion to null normal myocardium.
LGE in patients with cardiac devices
Performing CMR in patients with cardiac devices requires more complex screening procedures and changes to the imaging protocol in order to preserve safety and minimize image artifacts. In general, cardiac devices cause local image artifacts by disrupting the homogeneity of the magnetic field. For LGE, image artifacts are typically problematic when the device is large, (e.g., internal cardiac defibrillators) or in close proximity to the heart. The extent/size of the artifacts vary with the field strength (worse at 3 T than 1.5 T), readout type, and the use of conventional versus wideband inversion preparation pulses.
bSSFP pulse sequence variants are often hampered by the presence of off-resonance artifacts or large signal voids from the disruption of the magnetic field by the cardiac device. In comparison, GRE sequence variants tend to be resistant to off-resonance artifacts. However, in many cases, additional changes to a standard GRE implementation are still needed to reduce the impact of signal voids. For example, a typical implementation of GRE at 1.5 T (Table 1) may have large signal voids due to the rapid dephasing of spins near the device, and these artifacts often extend into the cardiac structures. Fortunately, the size of the signal void can be reduced by shortening the echo time, which is typically accomplished by increasing the receiver bandwidth (e.g., increasing to > 300 Hz/pixel at 1.5 T).
Off-resonance effects from an implanted device may also affect the ability of an inversion preparation to tip down spins. A device nearby the heart leads to a wider distribution of resonance frequencies within the heart (~ 2000–6000 Hz when a device is present vs 120 Hz when absent), which may exceed the spectral bandwidth of a conventional inversion pulse (~ 1000 Hz) [15,16,17]. Myocardium with resonance frequencies outside of the excitation bandwidth of the IR pulse are not inverted, thus creating an artifact that appears bright, irrespective of the presence of scar tissue.
Fortunately, in recent years, wideband (broadband) inversion pulses have become increasingly available to address this problem. A wideband inversion preparation has a larger spectral bandwidth (~ > 3000–4000 Hz) and is better able to tip down the full range of resonance frequencies within the heart when a device is present. Thus, normal myocardium can be uniformly nulled without the occurrence of bright artifacts due to this off-resonance effect. Although very useful in patients with cardiac devices, wideband inversions are not typically used in all patients because they require more power (B1) than conventional inversion pulses and have a lower inversion efficiency.
Dark blood LGE
Several dark blood LGE sequences have been described in the literature . In general, many of the pulse sequence parameters can be adjusted using the same guidelines as described above for bright blood LGE (SSIR-bSSFP and IR-GRE). However, since the mechanisms to generate image contrast between blood and infarcted myocardium are different, the process for selecting the optimal TI or other preparation time lengths to achieve dark blood conditions are sequence specific. A recent review describes the technical details of these sequences . As discussed earlier, we use FIDDLE for dark blood LGE, and now use it in place of segmented IR-GRE in most patients.
The typical pulse sequence parameters at 1.5 T and 3 T for segmented FIDDLE implementations used at our center are shown in Table 3. FIDDLE incorporates two preparation pulses with an bSSFP readout with phase sensitive reconstruction (Fig. 13) . First, a magnetization transfer (MT) preparation is used to reduce the magnetization of blood more than that of myocardium. Next, an IR preparation then separates the blood, infarcted myocardium, and normal myocardium on the basis of T1. Finally, with appropriate selection of the TI and phase sensitive reconstruction, the resultant image provides separation of the different tissue species. The sequence was designed to be modular, and in principle, other magnetization preparation combinations that result in the same net magnetization could be incorporated into the sequence. However, in our experience, the MT followed by IR preparation results in the most uniform blood nulling and no issues with specific absorption rate at either 1.5 T or 3 T [6, 19].
We do not typically adjust the parameters of the MT preparation. Instead, the effect of the MT preparation on in-vivo tissue signal were measured empirically, and the signal behavior of FIDDLE was modeled to optimize the MT preparation flip angle, train length, and offset frequency . As such, the MT parameters values are not typically changed (Table 3). Analogous to conventional bright blood LGE, however, we do manually adjust the FIDDLE inversion time (Fig. 13). We train the operators to pick a nominal TI (typically ~ 200 ms) and then based upon the image intensity of the blood pool, make an adjustment: if the blood pool is not black, the TI needs to be reduced; whereas, if the blood pool is black then the TI should be increased to the maximum value that still results in black blood. Usually, 1 or 2 test images are sufficient to find the optimal TI.
Image interpretation for viability
Prior to interpretation, we adjust the image window and level of each image so that (a) noise remains detectable (e.g., nulled myocardium is not a single image intensity) and (b) regions with LGE are not saturated (e.g., LGE regions are not a single image intensity). For clinical reporting, we interpret LGE images using the 17-segment model recommended by the American Heart Association . This model divides the basal and mid-cavities into six segments, and the apical cavity into four segments, with the true apex as one segment.
The mean transmural extent of LGE within each segment is visually graded using a 5-point scale, where 0 = no hyperenhancement; 1 = hyperenhancement of 1–25% of the segment; 2 = hyperenhancement of 26–50% of the segment; 3 = hyperenhancement of 51–75% of the segment; and 4 = hyperenhancement of 76–100% of the segment . We score the mean LGE transmural extent by visually comparing the region of LGE to the total wall thickness of the same segment where the LGE is present (LGE area/[LGE area + normal myocardium]) . This approach to analysis is particularly crucial in patients with wall thinning, as using an adjacent or remote wall with normal wall thickness can lead to a systematic underestimation of viability. Representative examples are shown in Fig. 14.
In patients with coronary artery disease, the mean transmural extent of LGE is used to assess myocardial viability and to predict the likelihood of recovery of contractile function following coronary revascularization . In myocardial segments with dysfunction, there is an inverse relationship between the mean transmural extent of LGE and the likelihood of improvement in contractility (Fig. 14). In other words, as the mean transmural extent of LGE decreases within a coronary perfusion territory, the likelihood of contractile function recovery increases if blood flow is restored.
LGE imaging has become an integral component of the clinical CMR core cardiac examination with implementations on every CMR platform. As the use of LGE has expanded to patients with more severe illnesses, patient specific adaptations of the LGE sequence are often needed to maintain diagnostic image quality. Through the adjustments to the standard LGE protocol described in this document, image quality can be systematically improved even in the setting of high-volume clinical practice.
Availability of data and materials
Balanced steady state free precession
Cardiovascular magnetic resonance
Flow independent dark blood delayed enhancement
Gadolinium based contrast agent
Late gadolinium enhancement
Left ventricle/left ventricular
Phase sensitive inversion recovery
Single shot inversion recovery
Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002. https://doi.org/10.1161/01.cir.100.19.1992.
Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson. 2003;5:505–14. https://doi.org/10.1081/jcmr-120022267.
Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Gadoversetamide Myocardial Infarction Imaging I. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117:629–37. https://doi.org/10.1161/CIRCULATIONAHA.107.723262.
Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of intravenous gadolinium-based contrast media in patients with kidney disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2021;298:28–35. https://doi.org/10.1148/radiol.2020202903.
Sievers B, Elliott MD, Hurwitz LM, Albert TS, Klem I, Rehwald WG, Parker MA, Judd RM, Kim RJ. Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation. 2007;115:236–44. https://doi.org/10.1161/CIRCULATIONAHA.106.635409.
Kim HW, Rehwald WG, Jenista ER, Wendell DC, Filev P, van Assche L, Jensen CJ, Parker MA, Chen EL, Crowley ALC, et al. Dark-blood delayed enhancement cardiac magnetic resonance of myocardial infarction. JACC Cardiovasc Imaging. 2018;11:1758–69. https://doi.org/10.1016/j.jcmg.2017.09.021.
Kellman P, Larson AC, Hsu LY, Chung YC, Simonetti OP, McVeigh ER, Arai AE. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med. 2005;53:194–200. https://doi.org/10.1002/mrm.20333.
Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215–23. https://doi.org/10.1148/radiology.218.1.r01ja50215.
Li W, Li BS, Polzin JA, Mai VM, Prasad PV, Edelman RR. Myocardial delayed enhancement imaging using inversion recovery single-shot steady-state free precession: initial experience. J Magn Reson Imaging. 2004;20:327–30. https://doi.org/10.1002/jmri.20095.
Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47:372–83. https://doi.org/10.1002/mrm.10051.
Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology. 2004;233:921–6. https://doi.org/10.1148/radiol.2333032004.
Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R, James OG, Patel MR, Heitner J, Parker M, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148–57. https://doi.org/10.1016/j.jacc.2008.03.041.
White JA, Kim HW, Shah D, Fine N, Kim KY, Wendell DC, Al-Jaroudi W, Parker M, Patel M, Gwadry-Sridhar F, et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:143–56. https://doi.org/10.1016/j.jcmg.2013.09.019.
Rashid S, Rapacchi S, Vaseghi M, Tung R, Shivkumar K, Finn JP, Hu P. Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. Radiology. 2014;270:269–74. https://doi.org/10.1148/radiol.13130942.
Stevens SM, Tung R, Rashid S, Gima J, Cote S, Pavez G, Khan S, Ennis DB, Finn JP, Boyle N, et al. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. Heart Rhythm. 2014;11:289–98. https://doi.org/10.1016/j.hrthm.2013.10.032.
Azevedo CF, Jenista ER, Kaolawanich Y, Kim HW, Wendell DC, Alenezi F, Chen EL, Parker MA, Judd RM, Kim RJ. Assessment of myocardial lipomatous metaplasia using an optimized out-of-phase cine steady-state free-precession sequence: validation and clinical implementation. NMR Biomed. 2022;35:e4777. https://doi.org/10.1002/nbm.4777.
Holtackers RJ, Van De Heyning CM, Chiribiri A, Wildberger JE, Botnar RM, Kooi ME. Dark-blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of subendocardial scar: a review of current techniques. J Cardiovasc Magn Reson. 2021;23:96. https://doi.org/10.1186/s12968-021-00777-6.
Jenista ER, Wendell DC, Kim HW, Rehwald WG, Chen EL, Darty SN, Smith LR, Azevedo CF, Parker MA, Kim RJ. Comparison of magnetization transfer-preparation and T2-preparation for dark-blood delayed-enhancement imaging. NMR Biomed. 2020;33:e4396. https://doi.org/10.1002/nbm.4396.
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–42.
Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53. https://doi.org/10.1056/NEJM200011163432003.
Shah DJ, Kim HW, James O, Parker M, Wu E, Bonow RO, Judd RM, Kim RJ. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA. 2013;309:909–18. https://doi.org/10.1001/jama.2013.1381.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Jenista, E.R., Wendell, D.C., Azevedo, C.F. et al. Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice. J Cardiovasc Magn Reson 25, 18 (2023). https://doi.org/10.1186/s12968-023-00925-0